Plasma CRABP2 as a Novel Biomarker in Patients with Non-Small Cell Lung Cancer

BACKGROUND: Lung cancer is the most common cause of cancer-related mortality worldwide. We previously reported the identification of a new genetic marker, cellular retinoic acid binding protein 2 (CRABP2), in lung cancer tissues. The aim of this study was to assess plasma levels of CRABP2 from patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Do Jun, Kim, Woo Jin, Lim, Myoungnam, Hong, Yoonki, Lee, Seung-Joon, Hong, Seok-Ho, Heo, Jeongwon, Lee, Hui-Young, Han, Seon-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010740/
https://www.ncbi.nlm.nih.gov/pubmed/29930489
http://dx.doi.org/10.3346/jkms.2018.33.e178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010740/
https://www.ncbi.nlm.nih.gov/pubmed/29930489
http://dx.doi.org/10.3346/jkms.2018.33.e178

Ejemplares similares